As midterm elections approach, the pharmacy industry is backing one of its most meaningful bills yet while the current congressional session wanes.
|Articles|September 28, 2007
Albemarle: Price of ibuprofen to increase
Albemarle to increase price of ibuprofen
Advertisement
Albemarle Corp., a global supplier of the active pharmaceutical ingredient ibuprofen, will increase the price of its ibuprofen 40 micron and ibuprofen 70 micron products by 12% and its ibuprofen 20 micron product by 20%, worldwide, effective Oct. 15 or as contracts allow. The company stated, "This price increase will allow us to continue to supply the industry with a consistent, reliable supply of what we believe is the highest quality ibuprofen available on the market today."
To go to the Drug Topics homepage,
Advertisement
Related to this article
Data found reduced cardiovascular risk with hormone therapy, particularly among Black women and those starting treatment within 10 years of menopause.
Eli Lilly’s new indication helps improve medication delivery for adults with type 2 diabetes, reducing annual injections by over 300.
Pennsylvania has become the center of the outbreak as cases exceed 775 alongside conflicting mortality reports.
The LATA trial found long-acting cabotegravir–rilpivirine is better than daily oral therapy at keeping adolescents virologically suppressed.
The update adds efficacy and safety data on adults newly diagnosed with pulmonary arterial hypertension.
Mark Garofoli, PharmD, BCGP, CPE, CTTS, explains how to guide patients past crowded combination products, uncertain decongestants, and hidden risks in OTC aisles.
Chad Worz, PharmD, BCGP, FASCP, explains why the Main Street Pharmacy Access Act's reimbursement provisions are key to unlocking pharmacy's clinical future.
Advertisement
Advertisement
Trending on Drug Topics
1
Injectable HIV Treatment Beats Daily Pills in Adolescent Trial
2
FDA Approves Onswik Weekly Insulin for Adults With T2D
3
Study Finds Reduced Cardiovascular Risk With Hormone Therapy Initiation
4
FDA Approves Update for Winrevair Based on Phase 3 HYPERION Trial Data
5